Flow cytometric quantitation of red blood cell vesicles in thalassemia.
BACKGROUND
Thalassemia is a hereditary hemolytic anemia caused by mutations in the globin gene complex. Circulatory disturbances including arterial and venous thrombosis have also been noted in these patients. Aggregability of abnormal RBC and the high level of membrane-derived microparticles stemming from activated platelets and other blood cells are thought to be responsible for the associated thrombotic risk. Destruction of RBC is also thought to be an important pathophysiological consequence, particularly through the formation of circulating vesicles. To our knowledge, there has been no attempt to quantitatively evaluate the number of RBC vesicles in thalassemia. This prompted us to study the level of RBC vesicles in the peripheral blood of thalassemia patients using quantitative flow cytometry.


METHODS
Whole blood from each subject was doubly stained for RBC and platelet or annexin V markers, together with the known density TruCount beads. RBC vesicles were gated according to their forward/side scatter and RBC marker. Percentage of RBC vesicles and their absolute number were analyzed by flow cytometry.


RESULTS
Our data indicated that RBC vesicles were annexin V-positive. The number of annexin V-positive events was higher than their intact RBCs. RBC vesicles were present in both normal and thalassemic blood samples, but the numbers of RBC vesicles were significantly higher in thalassemia. Both the percentage and the absolute number of RBC vesicles were especially marked in splenectomized subjects with beta-thalassemia/Hemoglobin E. When clinical and hematological indices were compared with RBC vesicles, there was an inverse relationship between the degree of severity in thalassemia patients and the number of RBC vesicles.


CONCLUSIONS
Flow cytometric quantitation of RBC vesicles is simple, reliable and may offer new insights in to study of the relationship between defective hemoglobin synthesis, RBC perturbation and pathophysiological complications in thalassemia.
Pattanapanyasat
Kovit
K
Center of Excellence for Flow Cytometry, Office for Research and Development, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand. grkpy@mahidol.ac.th
Noulsri
Egarit
E
Fucharoen
Suthat
S
Lerdwana
Surada
S
Lamchiagdhase
Pornvaree
P
Siritanaratkul
Napadol
N
Webster
H Kyle
HK
D000293:Adolescent; D000328:Adult; D017304:Annexin A5 / Q000097:blood; D015415:Biomarkers / Q000097:blood; D004906:Erythrocyte Count; D005434:Flow Cytometry / Q000379:methods*; D006801:Humans; D010976:Platelet Count; D012016:Reference Values; D012044:Regression Analysis; D017085:alpha-Thalassemia; D017086:beta-Thalassemia / Q000097:blood*
D017304:Annexin A5; D015415:Biomarkers